Published by Iain Gilbert on 31st March 2020
(Sharecast News) - Generic drugmaker Hikma Pharmaceuticals said on Tuesday that the US District Court of Nevada had ruled that its version of Amarin Corporation's Vascepa did not infringe six patents.
URL: http://www.digitallook.com/dl/news/story/30466540/...